Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer.

Harlan LC, Klabunde CN, Ambs AH, Gibson T, Bernstein L, McTiernan A, Meeske K, Baumgartner KB, Ballard-Barbash R.

J Cancer Surviv. 2009 Jun;3(2):89-98. doi: 10.1007/s11764-009-0084-3. Epub 2009 May 13.

2.

Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-Medicare data from 1993 to 2005.

Yasmeen S, Chlebowski RT, Xing G, Morris CR, Romano PS.

Cancer Med. 2013 Aug;2(4):526-36. doi: 10.1002/cam4.66. Epub 2013 Jun 24.

3.

Factors associated with surgical and radiation therapy for early stage breast cancer in older women.

Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG.

J Natl Cancer Inst. 1996 Jun 5;88(11):716-26.

PMID:
8637025
4.

Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study.

Togawa K, Ma H, Sullivan-Halley J, Neuhouser ML, Imayama I, Baumgartner KB, Smith AW, Alfano CM, McTiernan A, Ballard-Barbash R, Bernstein L.

Breast Cancer Res. 2014 Aug 22;16(4):414. doi: 10.1186/s13058-014-0414-x.

5.

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.

Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW.

JAMA. 2001 Feb 21;285(7):885-92.

PMID:
11180731
6.

Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.

Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP.

J Clin Oncol. 2010 Apr 20;28(12):2038-45. doi: 10.1200/JCO.2009.25.9796. Epub 2010 Mar 22.

7.

Risk factors for the development of uterine cancer in breast cancer survivors: an army of women study.

Torres D, Myers JA, Eshraghi LW, Riley EC, Soliman PT, Milam MR.

Ann Surg Oncol. 2015;22(6):1974-9. doi: 10.1245/s10434-014-4193-5. Epub 2014 Nov 1.

PMID:
25361886
8.

Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992-1995.

Richardson LC, Schulman J, Sever LE, Lee NC, Coate RJ.

Breast Cancer Res Treat. 2001 Sep;69(2):133-42.

PMID:
11759819
9.

Mortality impact of less-than-standard therapy in older breast cancer patients.

Yood MU, Owusu C, Buist DS, Geiger AM, Field TS, Thwin SS, Lash TL, Prout MN, Wei F, Quinn VP, Frost FJ, Silliman RA.

J Am Coll Surg. 2008 Jan;206(1):66-75. Epub 2007 Oct 3.

PMID:
18155570
10.

Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.

Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1005-15.

PMID:
10421533
11.

Symptoms after breast cancer treatment: are they influenced by patient characteristics?

Yoon J, Malin JL, Tao ML, Tisnado DM, Adams JL, Timmer MJ, Ganz PA, Kahn KL.

Breast Cancer Res Treat. 2008 Mar;108(2):153-65. Epub 2007 May 10.

PMID:
17492377
12.

Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial.

Ring A, Sestak I, Baum M, Howell A, Buzdar A, Dowsett M, Forbes JF, Cuzick J.

J Clin Oncol. 2011 Nov 10;29(32):4266-72. doi: 10.1200/JCO.2011.35.5545. Epub 2011 Oct 11.

PMID:
21990403
13.

Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.

Jordan JH, Thwin SS, Lash TL, Buist DS, Field TS, Haque R, Pawloski PA, Petersen HV, Prout MN, Quinn VP, Yood MU, Silliman RA, Geiger AM.

Breast Cancer Res Treat. 2014 Jul;146(2):401-9. doi: 10.1007/s10549-014-3021-8. Epub 2014 Jun 18.

14.

Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer.

Barlow WE, Taplin SH, Yoshida CK, Buist DS, Seger D, Brown M.

J Natl Cancer Inst. 2001 Mar 21;93(6):447-55.

PMID:
11259470
16.

The influence of young age on outcome in early stage breast cancer.

Fowble BL, Schultz DJ, Overmoyer B, Solin LJ, Fox K, Jardines L, Orel S, Glick JH.

Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):23-33.

PMID:
8083119
17.

Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer.

Field TS, Bosco JL, Prout MN, Gold HT, Cutrona S, Pawloski PA, Ulcickas Yood M, Quinn VP, Thwin SS, Silliman RA.

J Am Coll Surg. 2011 Dec;213(6):757-65. doi: 10.1016/j.jamcollsurg.2011.09.010. Epub 2011 Oct 19.

18.

Race as an independent risk factor for breast cancer survival: breast cancer outcomes from the medical college of georgia tumor registry.

Barcenas CH, Wells J, Chong D, French J, Looney SW, Samuel TA.

Clin Breast Cancer. 2010 Feb;10(1):59-63. doi: 10.3816/CBC.2010.n.008.

PMID:
20133260
19.

The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.

Sabatino SA, Thompson TD, Wu XC, Fleming ST, Kimmick GG, Trentham-Dietz A, Cress R, Anderson RT.

Breast Cancer Res Treat. 2014 Jul;146(1):199-209. doi: 10.1007/s10549-014-2998-3. Epub 2014 Jun 5.

PMID:
24899083
20.

Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer.

Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH.

J Clin Oncol. 2007 Sep 1;25(25):3808-15. Epub 2007 Jul 30.

PMID:
17664460

Supplemental Content

Support Center